Literature DB >> 19712125

Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection.

Elijah Paintsil1, Sergei V Verevochkin, Elena Dukhovlinova, Linda Niccolai, Russell Barbour, Edward White, Olga V Toussova, Louis Alexander, Andrei P Kozlov, Robert Heimer.   

Abstract

AIMS: To understand the epidemiology and transmission patterns of hepatitis C virus (HCV), the predominant blood borne-pathogen infecting injection drug users (IDUs), in a part of the former Soviet Union.
DESIGN: Cross-sectional respondent-driven sample of IDUs.
SETTING: St Petersburg, Russia. PARTICIPANTS: A total of 387 IDUs were recruited in late 2005 and throughout 2006. MEASUREMENTS: Participants were surveyed to collect demographic, medical and both general and dyad-specific drug injection and sexual behaviors. A blood sample was collected to detect antibodies to hepatitis C and to amplify viral RNA for molecular analysis. The molecular data, including genotypes, were analyzed spatially and linkage patterns were compared to the social linkages obtained by respondent-driven sampling (RDS) for chains of respondents and among the injection dyads.
FINDINGS: HCV infection was all but ubiquitous: 94.6% of IDUs were HCV-seropositive. Among the 209 viral sequences amplified, genotype 3a predominated (n = 119, 56.9%), followed by 1b (n = 61, 29.2%) and 1a (n = 25, 11.9%). There was no significant clustering of genotypes spatially. Neither genotypes nor closely related sequences were clustered within RDS chains. Analysis of HCV sequences from dyads failed to find associations of genotype or sequence homology within pairs.
CONCLUSIONS: Genotyping reveals that there have been at least five unique introductions of HCV genotypes into the IDU community in St Petersburg. Analysis of prevalent infections does not appear to correlate with the social networks of IDUs, suggesting that simple approaches to link these networks to prevalent infections, rather than incident transmission, will not prove meaningful. On a more positive note, the majority of IDUs are infected with 3a genotype that is associated with sustained virological response to antiviral therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19712125      PMCID: PMC2763027          DOI: 10.1111/j.1360-0443.2009.02687.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  63 in total

1.  Sociometric risk networks and risk for HIV infection.

Authors:  S R Friedman; A Neaigus; B Jose; R Curtis; M Goldstein; G Ildefonso; R B Rothenberg; D C Des Jarlais
Journal:  Am J Public Health       Date:  1997-08       Impact factor: 9.308

2.  Differences in epidemiology, liver disease and treatment response among HCV genotypes.

Authors:  Stephanos J. Hadziyannis; John S. Koskinas
Journal:  Hepatol Res       Date:  2004-07       Impact factor: 4.288

3.  Commercial sex work, drug use, and sexually transmitted infections in St. Petersburg, Russia.

Authors:  Sevgi O Aral; Janet S St Lawrence; Roman Dyatlov; Andrei Kozlov
Journal:  Soc Sci Med       Date:  2004-12-15       Impact factor: 4.634

Review 4.  Review of sampling hard-to-reach and hidden populations for HIV surveillance.

Authors:  Robert Magnani; Keith Sabin; Tobi Saidel; Douglas Heckathorn
Journal:  AIDS       Date:  2005-05       Impact factor: 4.177

5.  Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al.

Authors:  Gail V Matthews; Margaret Hellard; John Kaldor; Andrew Lloyd; Gregory J Dore
Journal:  AIDS       Date:  2007-10-01       Impact factor: 4.177

6.  [The current problems in the epidemiology and prevention of viral hepatitis B and C in the Russian Federation].

Authors:  G G Onishchenko; I V Shakhgil'dian
Journal:  Zh Mikrobiol Epidemiol Immunobiol       Date:  2000 Jan-Feb

7.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

8.  Norms, social networks, and HIV-related risk behaviors among urban disadvantaged drug users.

Authors:  Carl A Latkin; Valerie Forman; Amy Knowlton; Susan Sherman
Journal:  Soc Sci Med       Date:  2003-02       Impact factor: 4.634

9.  An individually tailored intervention for HIV prevention: baseline data from the EXPLORE Study.

Authors:  Margaret A Chesney; Beryl A Koblin; Patrick J Barresi; Marla J Husnik; Connie L Celum; Grant Colfax; Kenneth Mayer; David McKirnan; Franklyn N Judson; Yijian Huang; Thomas J Coates
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

10.  Genetic characterization of hepatitis C virus strains in Estonia: fluctuations in the predominating subtype with time.

Authors:  Tatjana Tallo; Helene Norder; Valentina Tefanova; Tõnu Krispin; Jelena Schmidt; Madis Ilmoja; Karen Orgulas; Kaije Pruunsild; Ludmilla Priimägi; Lars O Magnius
Journal:  J Med Virol       Date:  2007-04       Impact factor: 2.327

View more
  25 in total

1.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  Contraception use and unplanned pregnancies among injection drug-using women in St Petersburg, Russia.

Authors:  Nadia Abdala; Trace Kershaw; Tatiana V Krasnoselskikh; Andrei P Kozlov
Journal:  J Fam Plann Reprod Health Care       Date:  2011-04-14

Review 3.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

4.  Social networks and HCV viraemia in anti-HCV-positive rural drug users.

Authors:  A M Young; A B Jonas; J R Havens
Journal:  Epidemiol Infect       Date:  2012-04-19       Impact factor: 2.451

5.  Impact of incarceration experiences on reported HIV status and associated risk behaviours and disease comorbidities.

Authors:  Robert Heimer; Olga S Levina; Victoria Osipenko; Monica S Ruiz; Boris Sergeyev; Aleksander V Sirotkin; Inna Vyshemirskaya
Journal:  Eur J Public Health       Date:  2015-09-16       Impact factor: 3.367

6.  High-risk behaviors after release from incarceration among people who inject drugs in St. Petersburg, Russia.

Authors:  Javier A Cepeda; Linda M Niccolai; Alexandra Lyubimova; Trace Kershaw; Olga Levina; Robert Heimer
Journal:  Drug Alcohol Depend       Date:  2014-12-02       Impact factor: 4.492

7.  HEPATITIS C VIRUS GENOTYPES IN INJECTING DRUG USERS FROM ROMANIA.

Authors:  Camelia Sultana; Codruta Vagu; Aura Temereanca; Camelia Grancea; Josefina Slobozeanu; Simona Ruta
Journal:  Cent Eur J Med       Date:  2011-10

8.  Emergence of methadone as a street drug in St. Petersburg, Russia.

Authors:  Robert Heimer; Aleksandra Lyubimova; Russell Barbour; Olga S Levina
Journal:  Int J Drug Policy       Date:  2015-10-19

Review 9.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

10.  Social network-based recruitment successfully reveals HIV-1 transmission networks among high-risk individuals in El Salvador.

Authors:  Ann M Dennis; Wendy Murillo; Flor de Maria Hernandez; Maria Elena Guardado; Ana Isabel Nieto; Ivette Lorenzana de Rivera; Joseph J Eron; Gabriela Paz-Bailey
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.